ArticleBMC public health2025
Cohort profile: the Lebanon Study on Aging and HeAlth (LSAHA).
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Late Life Learning, Cognition, and Aging: A Longitudinal study of middle and older-aged adults in Beirut, Lebanon (3LC study).medRxiv : the preprint server for health sciences · 2026Article
- Recommended best practices for construct-centered adaptation of the Harmonized Cognitive Assessment Protocol.The journals of gerontology. Series B, Psychological sciences and social sciences · 2026Article
Corrections and comments
- Update of
Authors and funding
11 authors.
Funding
Abstract
backgroundThis paper describes the design and cohort profile of the Lebanon Study on Aging and HeAlth (LSAHA), the first population-level study of Alzheimer's Disease and Related Dementias (ADRD) in an Arab country. The burden due to ADRD in the Middle East and North Africa (MENA) region is among the highest in the world, but reliable population-level data on ADRD in the region are lacking. Older adults in Lebanon have experienced prolonged periods of social and economic instability due to political conflicts and chronic government mismanagement. The effects of these destabilizing experiences throughout the life course on ADRD risk and other late-life health outcomes are currently unknown.
methodsLSAHA is designed as a prospective cohort study of ADRD in a large sample of adults aged ≥ 60 years in Lebanon [baseline data presented here]. We employed a probability-based multi-stage sampling design in two pre-selected areas, the city of Beirut and district of Zahle, to represent the full range of urban-rural, socio-economic, and religious diversity in Lebanon. Data collection included a standardized survey questionnaire including validated cognitive tests and anthropometric measurements, a household interview, key informant assessments, and a blood sample. Survey weights were computed to account for differential non-response and calibrated for the age- and sex-distribution in the two study areas.
resultsLSAHA enrolled 3,027 participants, 1,510 from Beirut and 1,517 from Zahle, realizing a response rate of 69%. The average age of the sample was 71.7 years and 55.3% was female, 43.1% had primary education or less, while 19.9% had university training. There was a high prevalence of chronic medical conditions, such as hypertension (57.2%), heart disease (32.4%), and diabetes (32.7%). There was also a high prevalence of moderate/severe symptoms of depression (51.4%) and anxiety (34.1%). A substantial percentage reported fair or poor self-rated memory (52.1%) or having worse memory compared to 2 years ago (38.4%).
conclusionsWe successfully launched a new cohort study of older adults in Lebanon to investigate ADRD and its risk factors. Data from this study will inform clinical care and policy goals in Lebanon and other settings that face a rapidly growing number of older adults with ADRD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.